The Oncosearch | Oncotarget

Patient derived renal cell carcinoma xenografts exhibit distinct sensitivity patterns in response to antiangiogenic therapy and constitute a suitable tool for biomarker development Research Paper

Julia Schueler, Kerstin Klingner, Daniel Bug, Caren Zoeller, Armin Maier, Meng Dong, Kerstin Willecke, Anne-Lise Peille, Eva Steiner, Manuel Landesfeind, John A. Copland, Gabrielle M. Siegers, Axel Haferkamp, Katharina Boehm, Igor Tsaur, Meike Schneider

Published Jul 24, 2018 · Vol. 9, No. 57 · pp. 30946-30961

Selinexor reduces the expression of DNA damage repair proteins and sensitizes cancer cells to DNA damaging agents Research Paper

Trinayan Kashyap, Christian Argueta, Thaddeus Unger, Boris Klebanov, Sophia Debler, William Senapedis, Marsha L. Crochiere, Margaret S. Lee, Michael Kauffman, Sharon Shacham, Yosef Landesman

Published Jul 20, 2018 · Vol. 9, No. 56 · pp. 30773-30786

Silencing of casein kinase 1 delta reduces migration and metastasis of triple negative breast cancer cells Research Paper

Isabelle Bar, Ahmad Merhi, Lionel Larbanoix, Manuel Constant, Sandy Haussy, Sophie Laurent, Jean-Luc Canon, Paul DelrÃ©e

Published Jul 20, 2018 · Vol. 9, No. 56 · pp. 30821-30836

Prosopis juliflora (Sw.), DC induces apoptosis and cell cycle arrest in triple negative breast cancer cells: in vitro and in vivo investigations Research Paper

Bhimashankar Gurushidhappa Utage, Milind Shivajirao Patole, Punam Vasudeo Nagvenkar, Sonali Shankar Kamble, Rajesh Nivarti Gacche

Published Jul 13, 2018 · Vol. 9, No. 54 · pp. 30304-30323

Chk1 inhibition as a novel therapeutic strategy in melanoma Research Paper

Bor-Jang Hwang, Gautam Adhikary, Richard L. Eckert, A-Lien Lu

Published Jul 13, 2018 · Vol. 9, No. 54 · pp. 30450-30464

The matrix protein Fibulin-3 promotes KISS1R induced triple negative breast cancer cell invasion Research Paper

Michelle M. Noonan, Magdalena Dragan, Michael M. Mehta, David A. Hess, Muriel Brackstone, Alan B. Tuck, Navin Viswakarma, Ajay Rana, Andy V. Babwah, Frederic E. Wondisford, Moshmi Bhattacharya

Published Jul 10, 2018 · Vol. 9, No. 53 · pp. 30034-30052

Epigenetic activation of HORMAD1 in basal-like breast cancer: role in Rucaparib sensitivity Research Paper

Xian Wang, Ying Tan, Xixi Cao, Jin Ah Kim, Tianmeng Chen, Yiheng Hu, Matthew Wexler, Xiaosong Wang

Published Jul 10, 2018 · Vol. 9, No. 53 · pp. 30115-30127

Combined external beam radiotherapy with carbon ions and tumor targeting endoradiotherapy Clinical Research Papers

Claudius Melzig, Azadeh Fahim Golestaneh, Walter Mier, Christian Schwager, Samayita Das, Julian Schlegel, Felix Lasitschka, Hans-Ulrich Kauczor, JÃ¼rgen Debus, Uwe Haberkorn, Amir Abdollahi

Published Jul 6, 2018 · Vol. 9, No. 52 · pp. 29985-30004

RET fusions observed in lung and colorectal cancers are sensitive to ponatinib Research Paper

Joseph M. Gozgit, Tzu-Hsiu Chen, Youngchul Song, Scott Wardwell, Frank Wang, Jie Cai, Henry Li, Henrik Edgren, Victor M. Rivera, Justin Pritchard

Published Jul 3, 2018 · Vol. 9, No. 51 · pp. 29654-29664

Suppression of stress induction of the 78-kilodalton glucose regulated protein (GRP78) in cancer by IT-139, an anti-tumor ruthenium small molecule inhibitor Research Paper

Suzanne J. Bakewell, Daisy F. Rangel, Dat P. Ha, Jyothi Sethuraman, Richard Crouse, Emma Hadley, Tara L. Costich, Xingliang Zhou, Peter Nichols, Amy S. Lee

Published Jul 3, 2018 · Vol. 9, No. 51 · pp. 29698-29714

Inhibition of mTOR downregulates expression of DNA repair proteins and is highly efficient against BRCA2-mutated breast cancer in combination to PARP inhibition Research Paper

Rania El Botty, Florence Coussy, Rana Hatem, Franck Assayag, Sophie Chateau-Joubert, Jean-Luc Servely, Sophie Leboucher, Charles Fouillade, Sophie Vacher, BÃ©rengÃ¨re Ouine, AurÃ©lie Cartier, Leanne de Koning, Paul Cottu, Ivan BiÃ¨che, Elisabetta Marangoni

Published Jul 3, 2018 · Vol. 9, No. 51 · pp. 29587-29600

MGMT inhibition in ER positive breast cancer leads to CDC2, TOP2A, AURKB, CDC20, KIF20A, Cyclin A2, Cyclin B2, Cyclin D1, ERα and Survivin inhibition and enhances response to temozolomide Research Paper

George C. Bobustuc, Amin B. Kassam, Richard A. Rovin, Sheila Jeudy, Joshua S. Smith, Beth Isley, Maharaj Singh, Nathan David Sassoon, Kalkunte S. Srivenugopal, Santhi D. Konduri

Published Jul 3, 2018 · Vol. 9, No. 51 · pp. 29727-29742

A CARP-1 functional mimetic compound is synergistic with BRAF-targeting in non-small cell lung cancers Research Paper

Vino T. Cheriyan, Hashem Alsaab, Sreeja Sekhar, Jaganathan Venkatesh, Arindam Mondal, Imran Vhora, Samaresh Sau, Magesh Muthu, Lisa A. Polin, Edi Levi, Gerold Bepler, Arun K. Iyer, Mandip Singh, Arun K. Rishi

Published Jul 3, 2018 · Vol. 9, No. 51 · pp. 29680-29697

Survivin as a potential therapeutic target of acetylsalicylic acid in pituitary adenomas Research Paper

Kinga NÃ©meth, Nikolette SzÃ¼cs, SÃ¡ndor CzirjÃ¡k, Lilla Reiniger, BorbÃ¡la SzabÃ³, GÃ¡bor Barna, Katalin KarÃ¡szi, PÃ©ter Igaz, Vladimir Zivkovic, MÃ¡rta Korbonits, Attila PatÃ³cs, Henriett Butz

Published Jun 26, 2018 · Vol. 9, No. 49 · pp. 29180-29192

Development of an integrated CRISPRi targeting Î”Np63 for treatment of squamous cell carcinoma Research Paper

Masakazu Yoshida, Etsuko Yokota, Tetsushi Sakuma, Tomoki Yamatsuji, Nagio Takigawa, Toshikazu Ushijima, Takashi Yamamoto, Takuya Fukazawa, Yoshio Naomoto

Published Jun 26, 2018 · Vol. 9, No. 49 · pp. 29220-29232

Integrated treatment using intraperitoneal radioimmunotherapy and positron emission tomography-guided surgery with ⁶⁴Cu-labeled cetuximab to treat early- and late-phase peritoneal dissemination in human gastrointestinal cancer xenografts Research Paper

Yukie Yoshii, Mitsuyoshi Yoshimoto, Hiroki Matsumoto, Hideaki Tashima, Yuma Iwao, Hiroyuki Takuwa, Eiji Yoshida, Hidekatsu Wakizaka, Taiga Yamaya, Ming-Rong Zhang, Aya Sugyo, Sayaka Hanadate, Atsushi B. Tsuji, Tatsuya Higashi

Published Jun 22, 2018 · Vol. 9, No. 48 · pp. 28935-28950

The emergence of trophoblast cell-surface antigen 2 (TROP-2) as a novel cancer target Review

David M. Goldenberg, Rhona Stein, Robert M. Sharkey

Published Jun 22, 2018 · Vol. 9, No. 48 · pp. 28989-29006

2â€²-deoxy-2â€²-[18F] fluoro-D-glucose positron emission tomography, diffusion-weighted magnetic resonance imaging, and choline spectroscopy to predict the activity of cetuximab in tumor xenografts derived from patients with squamous cell carcinoma of the head and neck Research Paper

Lionel Mignion, Sandra Schmitz, Nicolas Michoux, Xavier Caignet, Rose-Marie Goebbels, Anne Bol, Marie-Aline C. Neveu, Vincent GrÃ©goire, Thierry Duprez, Renaud Lhommel, FrÃ©deric Amant, Els Hermans, Benedicte F. Jordan, Jean-Pascal Machiels

Published Jun 19, 2018 · Vol. 9, No. 47 · pp. 28572-28585

Deferasirox, an oral iron chelator, with gemcitabine synergistically inhibits pancreatic cancer cell growth in vitro and in vivo Research Paper

Shuhei Shinoda, Seiji Kaino, Shogo Amano, Hirofumi Harima, Toshihiko Matsumoto, Koichi Fujisawa, Taro Takami, Naoki Yamamoto, Takahiro Yamasaki, Isao Sakaida

Published Jun 19, 2018 · Vol. 9, No. 47 · pp. 28434-28444

The histone deacetylase inhibitor panobinostat is a potent antitumor agent in canine diffuse large B-cell lymphoma Research Paper

Joana N.R. Dias, Sandra I. Aguiar, Diane M. Pereira, Ana S. AndrÃ©, Lurdes Gano, JoÃ£o D.G. Correia, Belmira CarrapiÃ§o, Barbara RÃ¼tgen, Rui MalhÃ³, ConceiÃ§Ã£o Peleteiro, JoÃ£o Goncalves, CecÃlia M.P. Rodrigues, Solange Gil, LuÃs Tavares, Frederico Aires-da-Silva

Published Jun 19, 2018 · Vol. 9, No. 47 · pp. 28586-28598

Publication Alerts

European Cancer and Oncology Congress

Post-Publication Promotion

Search Oncotarget

Patient derived renal cell carcinoma xenografts exhibit distinct sensitivity patterns in response to antiangiogenic therapy and constitute a suitable tool for biomarker development Research Paper

Selinexor reduces the expression of DNA damage repair proteins and sensitizes cancer cells to DNA damaging agents Research Paper

Silencing of casein kinase 1 delta reduces migration and metastasis of triple negative breast cancer cells Research Paper

Prosopis juliflora (Sw.), DC induces apoptosis and cell cycle arrest in triple negative breast cancer cells: in vitro and in vivo investigations Research Paper

Chk1 inhibition as a novel therapeutic strategy in melanoma Research Paper

The matrix protein Fibulin-3 promotes KISS1R induced triple negative breast cancer cell invasion Research Paper

Epigenetic activation of HORMAD1 in basal-like breast cancer: role in Rucaparib sensitivity Research Paper

Combined external beam radiotherapy with carbon ions and tumor targeting endoradiotherapy Clinical Research Papers

RET fusions observed in lung and colorectal cancers are sensitive to ponatinib Research Paper

Suppression of stress induction of the 78-kilodalton glucose regulated protein (GRP78) in cancer by IT-139, an anti-tumor ruthenium small molecule inhibitor Research Paper

Inhibition of mTOR downregulates expression of DNA repair proteins and is highly efficient against BRCA2-mutated breast cancer in combination to PARP inhibition Research Paper

MGMT inhibition in ER positive breast cancer leads to CDC2, TOP2A, AURKB, CDC20, KIF20A, Cyclin A2, Cyclin B2, Cyclin D1, ERα and Survivin inhibition and enhances response to temozolomide Research Paper

A CARP-1 functional mimetic compound is synergistic with BRAF-targeting in non-small cell lung cancers Research Paper

Survivin as a potential therapeutic target of acetylsalicylic acid in pituitary adenomas Research Paper

Development of an integrated CRISPRi targeting Î”Np63 for treatment of squamous cell carcinoma Research Paper

Integrated treatment using intraperitoneal radioimmunotherapy and positron emission tomography-guided surgery with ⁶⁴Cu-labeled cetuximab to treat early- and late-phase peritoneal dissemination in human gastrointestinal cancer xenografts Research Paper

The emergence of trophoblast cell-surface antigen 2 (TROP-2) as a novel cancer target Review

2â€²-deoxy-2â€²-[18F] fluoro-D-glucose positron emission tomography, diffusion-weighted magnetic resonance imaging, and choline spectroscopy to predict the activity of cetuximab in tumor xenografts derived from patients with squamous cell carcinoma of the head and neck Research Paper

Deferasirox, an oral iron chelator, with gemcitabine synergistically inhibits pancreatic cancer cell growth in vitro and in vivo Research Paper

The histone deacetylase inhibitor panobinostat is a potent antitumor agent in canine diffuse large B-cell lymphoma Research Paper

Publication Alerts

European Cancer and Oncology Congress

Oncoscience

Post-Publication Promotion

Search Oncotarget

Patient derived renal cell carcinoma xenografts exhibit distinct sensitivity patterns in response to antiangiogenic therapy and constitute a suitable tool for biomarker development Research Paper

Selinexor reduces the expression of DNA damage repair proteins and sensitizes cancer cells to DNA damaging agents Research Paper

Silencing of casein kinase 1 delta reduces migration and metastasis of triple negative breast cancer cells Research Paper

Prosopis juliflora (Sw.), DC induces apoptosis and cell cycle arrest in triple negative breast cancer cells: in vitro and in vivo investigations Research Paper

Chk1 inhibition as a novel therapeutic strategy in melanoma Research Paper

The matrix protein Fibulin-3 promotes KISS1R induced triple negative breast cancer cell invasion Research Paper

Epigenetic activation of HORMAD1 in basal-like breast cancer: role in Rucaparib sensitivity Research Paper

Combined external beam radiotherapy with carbon ions and tumor targeting endoradiotherapy Clinical Research Papers

RET fusions observed in lung and colorectal cancers are sensitive to ponatinib Research Paper

Suppression of stress induction of the 78-kilodalton glucose regulated protein (GRP78) in cancer by IT-139, an anti-tumor ruthenium small molecule inhibitor Research Paper

Inhibition of mTOR downregulates expression of DNA repair proteins and is highly efficient against BRCA2-mutated breast cancer in combination to PARP inhibition Research Paper

MGMT inhibition in ER positive breast cancer leads to CDC2, TOP2A, AURKB, CDC20, KIF20A, Cyclin A2, Cyclin B2, Cyclin D1, ERα and Survivin inhibition and enhances response to temozolomide Research Paper

A CARP-1 functional mimetic compound is synergistic with BRAF-targeting in non-small cell lung cancers Research Paper

Survivin as a potential therapeutic target of acetylsalicylic acid in pituitary adenomas Research Paper

Development of an integrated CRISPRi targeting Î”Np63 for treatment of squamous cell carcinoma Research Paper

Integrated treatment using intraperitoneal radioimmunotherapy and positron emission tomography-guided surgery with 64Cu-labeled cetuximab to treat early- and late-phase peritoneal dissemination in human gastrointestinal cancer xenografts Research Paper

The emergence of trophoblast cell-surface antigen 2 (TROP-2) as a novel cancer target Review

2â€²-deoxy-2â€²-[18F] fluoro-D-glucose positron emission tomography, diffusion-weighted magnetic resonance imaging, and choline spectroscopy to predict the activity of cetuximab in tumor xenografts derived from patients with squamous cell carcinoma of the head and neck Research Paper

Deferasirox, an oral iron chelator, with gemcitabine synergistically inhibits pancreatic cancer cell growth in vitro and in vivo Research Paper

The histone deacetylase inhibitor panobinostat is a potent antitumor agent in canine diffuse large B-cell lymphoma Research Paper

Integrated treatment using intraperitoneal radioimmunotherapy and positron emission tomography-guided surgery with ⁶⁴Cu-labeled cetuximab to treat early- and late-phase peritoneal dissemination in human gastrointestinal cancer xenografts Research Paper